Loading clinical trials...
Loading clinical trials...
A Randomized, Placebo-controlled, Double-blinded, Multicenter Study of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to Placebo, in Adult Subjects With Chronic Idiopathic Constipation
Conditions
Interventions
Lubiprostone
Placebo
Locations
67
United States
Investigative Site
Birmingham, Alabama, United States
Investigative Site
Foley, Alabama, United States
Investigative Site
Little Rock, Arkansas, United States
Investigative Site
Anaheim, California, United States
Investigative Sitee
Chula Vista, California, United States
Investigative Site
Garden Grove, California, United States
Start Date
March 13, 2017
Primary Completion Date
August 17, 2017
Completion Date
August 17, 2017
Last Updated
January 14, 2020
NCT04838522
NCT06736912
NCT03879239
NCT02819297
NCT01982240
NCT03551873
Lead Sponsor
Sucampo Pharma Americas, LLC
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions